Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$146.52 - $269.56 $330,256 - $607,588
-2,254 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$249.6 - $403.14 $274,560 - $443,454
-1,100 Reduced 32.8%
2,254 $818,000
Q4 2020

Feb 11, 2021

SELL
$221.31 - $316.61 $1.97 Million - $2.82 Million
-8,900 Reduced 72.63%
3,354 $867,000
Q1 2020

May 01, 2020

BUY
$121.84 - $173.19 $67,499 - $95,947
554 Added 4.74%
12,254 $1.51 Million
Q1 2019

Apr 30, 2019

SELL
$122.82 - $151.83 $98,256 - $121,464
-800 Reduced 6.4%
11,700 $1.54 Million
Q4 2018

Feb 08, 2019

BUY
$107.01 - $175.15 $1.34 Million - $2.19 Million
12,500 New
12,500 $1.75 Million

Others Institutions Holding BGNE

About BeiGene, Ltd.


  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $18.6B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Public Employees Retirement Association Of Colorado Portfolio

Follow Public Employees Retirement Association Of Colorado and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement Association Of Colorado, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement Association Of Colorado with notifications on news.